AXIM (AXIM Biotechnologies) Days Inventory: 0.00 (As of Jun. 2025)


What is AXIM Biotechnologies Days Inventory?

AXIM Biotechnologies AXIM -16.00% Days Inventory is 0.00 as of Jun. 2025. The stock has 7 warning signs investors should review. Among 640 Biotechnology companies, AXIM Biotechnologies ranks worse than 156249.84% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). AXIM Biotechnologies's Average Total Inventories for the three months ended in Jun. 2025 was $0.00 Mil. AXIM Biotechnologies's Cost of Goods Sold for the three months ended in Jun. 2025 was $0.00 Mil.

The historical rank and industry rank for AXIM Biotechnologies's Days Inventory or its related term are showing as below:

During the past 13 years, AXIM Biotechnologies's highest Days Inventory was 1467.30. The lowest was 199.48. And the median was 334.26.

AXIM's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.145
* Ranked among companies with meaningful Days Inventory only.

AXIM Biotechnologies's Days Inventory stayed the same from Mar. 2024 (0.00) to Jun. 2025 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. AXIM Biotechnologies's Inventory Turnover for the three months ended in Jun. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


AXIM Biotechnologies  (OTCPK:AXIM) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

AXIM Biotechnologies's Inventory Turnover for the three months ended in Jun. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AXIM Biotechnologies's Inventory to Revenue for the three months ended in Jun. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


AXIM Biotechnologies Days Inventory Related Terms


AXIM Biotechnologies Days Inventory Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Days Inventory Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,277.50 0.00 0.00 0.00

AXIM vs HEPA, SCNI, BZYR: Days Inventory Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AXIM Biotechnologies Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Days Inventory distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Days Inventory falls into.



AXIM Biotechnologies Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AXIM Biotechnologies's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

Days Inventory (A: Dec. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0.007*365
=0 / 0.007*365
=0.00

AXIM Biotechnologies's Days Inventory for the quarter that ended in Jun. 2025 is calculated as:

Days Inventory (Q: Jun. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2025 ) + Total Inventories (Q: Jun. 2025 )) / count ) / Cost of Goods Sold (Q: Jun. 2025 )*Days in Period
=( (0.001 + 0) / 1 ) / 0*365 / 4
=0.001 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
AXIM Biotechnologies (AXIM) has a Days Inventory of 0.00 as of Jun. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AXIM Biotechnologies and its competitors. Over the past decade, AXIM Biotechnologies' Days Inventory has ranged from 199.48 to 1,467.30. According to the industry distribution chart, AXIM Biotechnologies ranks #999999 out of 640 companies in the Biotechnology industry.
Is AXIM Biotechnologies' Days Inventory too high?
AXIM Biotechnologies' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 199.48 to a high of 1,467.30. Based on the distribution chart, AXIM Biotechnologies ranks #999999 out of 640 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does AXIM Biotechnologies' Days Inventory compare to HEPA and SCNI?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #999999 out of 640 companies for Days Inventory. This places AXIM Biotechnologies in the lower half of its industry. The industry median Days Inventory is 184.15. Historically, AXIM Biotechnologies' own Days Inventory has ranged from 199.48 to 1,467.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AXIM Biotechnologies and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Days Inventory is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.